Leff T - Search Results

1

Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency.

Campeau PM, Astapova O, Martins R, Bergeron J, Couture P, Hegele RA, Leff T, Gagné C. Campeau PM, et al. Among authors: leff t. J Lipid Res. 2012 Sep;53(9):1968-78. doi: 10.1194/jlr.P025437. Epub 2012 Jul 2. J Lipid Res. 2012. PMID: 22750678 Free PMC article.

2

PPARγ mutations, lipodystrophy and diabetes.

Astapova O, Leff T. Astapova O, et al. Among authors: leff t. Horm Mol Biol Clin Investig. 2014 Nov;20(2):63-70. doi: 10.1515/hmbci-2014-0033. Horm Mol Biol Clin Investig. 2014. PMID: 25460295 Review.

3

Unbuckling lipodystrophy from insulin resistance and hypertension.

Hegele RA, Leff T. Hegele RA, et al. Among authors: leff t. J Clin Invest. 2004 Jul;114(2):163-5. doi: 10.1172/JCI22382. J Clin Invest. 2004. PMID: 15254581 Free PMC article.

4

Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.

Monajemi H, Zhang L, Li G, Jeninga EH, Cao H, Maas M, Brouwer CB, Kalkhoven E, Stroes E, Hegele RA, Leff T. Monajemi H, et al. Among authors: leff t. J Clin Endocrinol Metab. 2007 May;92(5):1606-12. doi: 10.1210/jc.2006-1807. Epub 2007 Feb 13. J Clin Endocrinol Metab. 2007. PMID: 17299075

5

Adiponectin and PPARγ: cooperative and interdependent actions of two key regulators of metabolism.

Astapova O, Leff T. Astapova O, et al. Among authors: leff t. Vitam Horm. 2012;90:143-62. doi: 10.1016/B978-0-12-398313-8.00006-3. Vitam Horm. 2012. PMID: 23017715 Review.

6

PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.

Hegele RA, Cao H, Frankowski C, Mathews ST, Leff T. Hegele RA, et al. Among authors: leff t. Diabetes. 2002 Dec;51(12):3586-90. doi: 10.2337/diabetes.51.12.3586. Diabetes. 2002. PMID: 12453919

7

Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3).

Francis GA, Li G, Casey R, Wang J, Cao H, Leff T, Hegele RA. Francis GA, et al. Among authors: leff t. BMC Med Genet. 2006 Jan 14;7:3. doi: 10.1186/1471-2350-7-3. BMC Med Genet. 2006. PMID: 16412238 Free PMC article.

8

Efficacy and safety of pioglitazone in treatment of a patient with an atypical partial lipodystrophy syndrome.

Sleilati GG, Leff T, Bonnett JW, Hegele RA. Sleilati GG, et al. Among authors: leff t. Endocr Pract. 2007 Oct;13(6):656-61. doi: 10.4158/EP.13.6.656. Endocr Pract. 2007. PMID: 17954424

9

Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels.

Chen M, Breslow JL, Li W, Leff T. Chen M, et al. Among authors: leff t. J Lipid Res. 1994 Nov;35(11):1918-24. J Lipid Res. 1994. PMID: 7868970 Free article.

10

Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.

Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen X, Vanbogelen R, Leff T. Camp HS, et al. Among authors: leff t. Diabetes. 2000 Apr;49(4):539-47. doi: 10.2337/diabetes.49.4.539. Diabetes. 2000. PMID: 10871190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page